2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy

May 9, 2019—The expert consensus statement defines the broader condition of arrhythmogenic cardiomyopathy (ACM) that incorporates a spectrum of genetic, systematic, infectious, and inflammatory disorders. The designation includes, but is not limited to, arrhythmogenic right/left ventricular cardiomyopathy, ion channel abnormalities, amyloidosis, and left ventricular noncompaction.

The consensus statement provides the clinician with guidance on evaluation and management of ACM and includes clinically relevant information on genetics and disease mechanisms. PICO (Patient, Intervention, Comparison, Outcome) questions were utilized to evaluate contemporary evidence and provide clinical guidance related to exercise in arrhythmogenic right ventricular cardiomyopathy.

The document features an Executive Summary and a video interview with the Chair of the Writing Committee, Jeffrey A. Towbin, MS, MD, by Heart Rhythm Journal Online Editor Daniel P. Morin, MD, MPH, FHRS.

The Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy pocket guide, a valuable educational reference tool developed in partnership with Guideline Central, is available across multiple platforms, including print, electronic media, and the Guideline Central mobile app.